Andere talen Hyper Corporation Inc.

Aandelen

A065650

KR7065650004

slotkoers Korea S.E. Andere beurzen 00:00:00 16-05-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
1.463 ^KRW	+1,39%		-3,18%	+48,83%

28/03

FSN Co. (KOSDAQ:A214270), AI Tech Fund, Asset Plus Fund en Open Innovation Fund beheerd door Benex Investment voltooiden de overname van een belang van 22,4% in Medifron DBT Co. (KOSDAQ:A065650) van Hansung Cleantech Co., Ltd. (KOSDAQ:A066980) en T Scientific Co.,Ltd. (KOSDAQ:A057680)

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Medifron DBT Co., Ltd. announced that it has received KRW 20.999999826 billion in funding from FSN Co., Ltd.	26/04
Medifron DBT Co., Ltd. agreed to acquire 31.8% stake in Fingerlabs Co., Ltd. from FSN Co., Ltd..	05/04
AdQUA Interactive Inc. agreed to acquire 48% stake in Emotion Global, Inc. from Medifron DBT Co., Ltd. for KRW 5.9 billion.	05/04
Medifron DBT Co., Ltd. agreed to acquire 19.49% stake in Makeus Co.,Ltd. from FSN Co., Ltd. for KRW 7.9 billion.	05/04
FSN Co., Ltd., AI Tech Fund, Asset Plus Fund and Open Innovation Fund managed by Benex Investment completed the acquisition of a 22.4% stake in Medifron DBT Co., Ltd. from Hansung Cleantech Co., Ltd. and T Scientific Co.,Ltd.	28/03
EN Creative Co., Ltd. agreed to acquire HMR business of Medifron DBT Co., Ltd. for KRW 5.7 billion	16/02
Medifron DBT Co., Ltd. announced that it expects to receive KRW 41.999999652 billion in funding	15/02
Medifron DBT Co., Ltd. announced that it expects to receive KRW 20.999999826 billion in funding from FSN Co., Ltd.	15/02
Medifron DBT Co., Ltd. announced that it has received KRW 4.0000092 billion in funding from T Scientific Co.,Ltd	14-12-22
Medifron DBT Co., Ltd.(KOSDAQ:A065650) dropped from S&P Global BMI Index	19-09-22
Medifron DBT Co., Ltd. announced that it has received KRW 3 billion in funding	24-08-22
Medifron DBT Co., Ltd. announced that it expects to receive KRW 3 billion in funding	22-08-22
Medifron DBT Co., Ltd. announced that it has received KRW 5 billion in funding from Shinhan Financial Investment Co., Ltd., Mirae Asset Securities Co. Ltd., NH Investment & Securities Co., Ltd., KB Securities Co., Ltd.	30-06-22
Medifron DBT to Raise $3.9 Million via Stock Offering	22-06-22
Medifron DBT to Raise $10 Million via Stock Offering	22-06-22
Medifron DBT Co., Ltd. announced that it expects to receive KRW 5 billion in funding from Shinhan Financial Investment Co., Ltd., Mirae Asset Securities Co. Ltd., NH Investment & Securities Co., Ltd., KB Securities Co., Ltd.	22-06-22
Medifron DBT Co., Ltd. announced that it expects to receive KRW 12.9999915 billion in funding from Best Investment & Securities Co., Ltd., Hanyang Securities Co. Ltd., Korea Investment & Securities Co., Ltd., NH Investment & Securities Co., Ltd., KB Securities Co., Ltd. and other investors	22-06-22
Medifron DBT Co., Ltd. announced that it expects to receive KRW 4.9999995 billion in funding from T Scientific Co.,Ltd	22-06-22
Medifron DBT Co., Ltd. announced that it has received KRW 4 billion in funding from Kiwoom Securities Co., Ltd., Investment Arm	15-09-21
Medifron DBT Co., Ltd. announced that it expects to receive KRW 4 billion in funding from Kiwoom Securities Co., Ltd., Investment Arm	13-09-21

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Hyper Corporation Inc.

Aandelen

A065650

KR7065650004

Andere talen

Filters